
U S Physical Therapy Inc
USPHNYSECIK 885978HealthcareFiscal year ends Dec 31
Reports and events: 523 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-08-2311:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000039 |
| 2018-08-0715:38 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001140361-18-035759 |
| 2018-08-0208:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-18-000037 |
| 2018-07-2414:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-18-000035 |
| 2018-05-3114:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000033 |
| 2018-05-2309:03 ET | 8-K | 5.07 Shareholder vote results | 0000885978-18-000031 |
| 2018-05-2112:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000028 |
| 2018-05-1612:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000026 |
| 2018-05-0711:39 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001140361-18-021886 |
| 2018-05-0412:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000024 |
| 2018-05-0308:38 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-18-000022 |
| 2018-05-0109:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-18-000020 |
| 2018-04-1209:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-18-000018 |
| 2018-04-0511:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000016 |
| 2018-04-0511:00 ET | DEF 14A | Proxy statementPeriod 2018-05-22 | 0001140361-18-017366 |
| 2018-03-1409:50 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001140361-18-013378 |
| 2018-03-1315:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000013 |
| 2018-03-0815:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000011 |
| 2018-03-0808:33 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-18-000009 |
| 2018-03-0710:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-18-000006 |
| 2018-02-0909:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-18-000004 |
| 2018-01-0917:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-18-000002 |
| 2017-11-1414:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-17-042646 |
| 2017-11-0915:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-17-000038 |
| 2017-11-0714:43 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001140361-17-041348 |
| 2017-11-0209:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-17-000036 |
| 2017-11-0115:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-17-000034 |
| 2017-11-0109:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-17-000032 |
| 2017-10-0314:30 ET | 8-K | 5.07 Shareholder vote results | 0000885978-17-000030 |
| 2017-09-2516:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-17-000028 |
| 2017-09-2012:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-17-000026 |
| 2017-09-1116:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-17-002484 |
| 2017-08-2511:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-17-000024 |
| 2017-08-1512:13 ET | DEF 14A | Proxy statementPeriod 2017-10-03 | 0001567619-17-001703 |
| 2017-08-1114:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-17-031333 |
| 2017-08-0714:36 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001140361-17-030329 |
| 2017-08-0308:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-17-002276 |
| 2017-07-1316:32 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-17-027785 |
| 2017-07-1214:35 ET | 8-K | 8.01 Other events | 0001140361-17-027681 |
| 2017-07-0508:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-17-001914 |
| 2017-06-2914:19 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001140361-17-026618 |
| 2017-06-2908:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-17-001894 |
| 2017-06-0717:20 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001140361-17-024382 |
| 2017-06-0715:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-17-000021 |
| 2017-06-0708:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-17-001742 |
| 2017-06-0108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-17-001708 |
| 2017-05-3117:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-17-023122 |
| 2017-05-3111:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-17-000019 |
| 2017-05-1008:11 ET | 8-K | 2.02 Results of operations | 0000885978-17-000017 |
| 2017-04-2816:15 ET | 8-K | 8.01 Other events | 0000885978-17-000015 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.